Researchers at Stanford have created ligand-induced dimerization activating RNA editing (LIDAR), a versatile molecular sensor that turns the presence of a ligand into translation of an output protein.
Stanford researchers have designed a remote digital health platform to assist diagnosis and management of some inflammatory skin conditions, such as eczema.
The Stanford Sarafan ChEM-H Medicinal Chemistry Knowledge Center has developed a novel aqueous solubilizing promoiety (Sol-moiety) that can be readily attached to a wide-range of functional groups and undergo controlled cleavage to improve the pharmacokinetic profile of a desi
Researchers in the DeSimone Research Group have developed a high-resolution injection Continuous Liquid Interface Production (iCLIP) 3D printing process.
Stanford researchers at the Lee Lab have developed a new system and method for measuring pathology then applying a novel algorithm to optimize neurostimulation therapy for altering pathology for treatment of neurodegenerative diseases.
Stanford researchers at the Lee Lab have developed a method to understand whole-brain circuit mechanisms underlying neurological disease and its application to predict the outcome of therapeutic interventions.
Stanford researchers have developed novel designs for 3D-printed microarray patches (MAPs) that can improve intradermal drug delivery and sampling. These designs support the use of microneedles for minimally invasive therapy administration and diagnostics.
Stanford researchers have developed a patient classification method (healthy, idiopathic, diabetic, etc.) based on a quantitative assessment score derived from autonomic and gastric electrocardiogram (ECG) and electrogastrogram (EGG) data.
Stanford researchers have developed an expanded catalog of compact transcription effector domains and fused them onto DNA binding domains to engineer synthetic transcription factors.
Researchers at Stanford and the University of Helsinki discovered that a human secretoglobin protein found in sweat gland cells acts as a novel host defense mechanism against Lyme disease.
Stanford researchers in the Lin Lab have identified kinase-modulated bioluminescent indicators (KiMBIs) which can assess real time kinase inhibition in target tissues in vivo.
Stanford scientists in Chris Garcia's lab have developed leptin analogs that have potentially more favorable pharmacokinetic and pharmacological signaling properties for use as diabetes and obesity drugs.
Stanford researchers at the Bao Lab have designed hydrophobic perfluoropolyether (PFPE) polymers that can be applied in underwater conditions, at room temperature, without any solvent or curing steps, and can be reused and recycled.